Yvonne Rosenstein

7PUBLICATIONS
22CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiology (incl. cardiovascular diseases)Molecular medicineGenome structure and regulationPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 27, 2026
CD43: recent advances and emerging functions.

|Dec 12, 2025
Neurological manifestations with jugular vein thrombosis linked to an inflammatory profile may be a sequela of long COVID.

Elizabeth Mendoza-Portillo, Estefania Aleman-Navarro, G Aleph Prieto

|Jan 22, 2024
Characterization of a New Immunosuppressive and Antimicrobial Peptide, DRS-DA2, Isolated from the Mexican Frog, Pachymedusa dacnicolor.

Claire Lacombe, Estefania Aleman-Navaro, Thierry Drujon

|Jul 27, 2022
The Ca2+ Channel Blocker Verapamil Inhibits the In Vitro Activation and Function of T Lymphocytes: A 2022 Reappraisal.

José Ignacio Veytia-Bucheli, Den Alejandro Alvarado-Velázquez, Lourival Domingos Possani

|Feb 03, 2021
CD43 (sialophorin) is involved in the induction of extracellular matrix remodeling and angiogenesis by lung cancer cells.

Daniela Vega-Mendoza, Alicia Cañas-Linares, Angel Flores-Alcantar

Pageof 2